During the recent session, Kintara Therapeutics Inc (NASDAQ:KTRA)’s traded shares were 9.18 million, with the beta value of the company hitting 0.96. At the last check today, the stock’s price was $0.30, reflecting an intraday loss of -7.16% or -$0.03. The 52-week high for the KTRA share is $5.60, that puts it down -1766.67 from that peak though still a striking 73.33% gain since the share price plummeted to a 52-week low of $0.08. The company’s market capitalization is $16.78M, and the average trade volume was 16.42 million shares over the past three months.
Kintara Therapeutics Inc (NASDAQ:KTRA) trade information
Kintara Therapeutics Inc (KTRA) registered a -7.16% downside in the last session and has traded in the green over the past 5 sessions. The stock plummet -7.16% in intraday trading to $0.30, hitting a weekly high. The stock’s 5-day price performance is 10.40%, and it has moved by 61.52% in 30 days. Based on these gigs, the overall price performance for the year is -89.85%.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 49.09%.
KTRA Dividends
Kintara Therapeutics Inc is due to release its next quarterly earnings in July. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
